Charles River Laboratories International, Inc.
CRLNYSECIK 1100682IndustrialsFiscal year ends Dec 27
Reports and events: 278 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2408:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001100682-26-000142 |
| 2026-08-0509:21 ET | 10-Q | Quarterly reportPeriod 2026-06-27 | 0001100682-26-000118 |
| 2026-08-0507:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-26-000115 |
| 2026-05-1117:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950103-26-007060 |
| 2026-05-0716:14 ET | 10-Q | Quarterly reportPeriod 2026-03-28 | 0001100682-26-000038 |
| 2026-05-0707:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-26-000036 |
| 2026-03-3107:50 ET | DEF 14A | Proxy statementPeriod 2026-05-05 | 0001104659-26-037367 |
| 2026-02-2507:34 ET | 8-K | 7.01 Regulation FD disclosure | 0001628280-26-011395 |
| 2026-02-1816:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950103-26-002326 |
| 2026-02-1809:21 ET | 10-K | Annual reportPeriod 2025-12-27 | 0001100682-26-000022 |
| 2026-02-1807:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-26-000020 |
| 2026-01-1308:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001628280-26-001905 |
| 2026-01-0916:18 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-001603 |
| 2025-12-0307:28 ET | 8-K | 7.01 Regulation FD disclosure | 0001628280-25-054902 |
| 2025-11-1708:06 ET | 8-K | 8.01 Other events | 0001628280-25-052484 |
| 2025-11-0509:12 ET | 10-Q | Quarterly reportPeriod 2025-09-27 | 0001100682-25-000043 |
| 2025-11-0507:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-25-000041 |
| 2025-09-1916:14 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0000950103-25-011896 |
| 2025-09-1607:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-25-011676 |
| 2025-08-0609:07 ET | 10-Q | Quarterly reportPeriod 2025-06-28 | 0001100682-25-000034 |
| 2025-08-0607:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-25-000032 |
| 2025-05-2316:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001100682-25-000023 |
| 2025-05-0709:09 ET | 10-Q | Quarterly reportPeriod 2025-03-29 | 0001100682-25-000021 |
| 2025-05-0707:15 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-25-005798 |
| 2025-05-0707:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-25-000019 |
| 2025-04-0208:00 ET | DEF 14A | Proxy statementPeriod 2025-05-20 | 0001104659-25-030908 |
| 2025-02-2116:30 ET | 8-K | 8.01 Other events | 0001100682-25-000014 |
| 2025-02-1909:07 ET | 10-K | Annual reportPeriod 2024-12-28 | 0001100682-25-000011 |
| 2025-02-1907:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-25-000009 |
| 2025-01-1408:04 ET | 8-K | 7.01 Regulation FD disclosure | 0001100682-25-000003 |
| 2024-12-1316:42 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950103-24-017767 |
| 2024-11-0609:16 ET | 10-Q | Quarterly reportPeriod 2024-09-28 | 0001100682-24-000035 |
| 2024-11-0607:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-24-000033 |
| 2024-08-0709:15 ET | 10-Q | Quarterly reportPeriod 2024-06-29 | 0001100682-24-000027 |
| 2024-08-0707:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-24-000025 |
| 2024-05-1016:07 ET | 8-K | 5.07 Shareholder vote results | 0001100682-24-000020 |
| 2024-05-0909:17 ET | 10-Q | Quarterly reportPeriod 2024-03-30 | 0001100682-24-000018 |
| 2024-05-0907:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001100682-24-000014 |
| 2024-03-2908:00 ET | DEF 14A | Proxy statementPeriod 2024-05-08 | 0001104659-24-040854 |
| 2024-02-1409:19 ET | 10-K | Annual reportPeriod 2023-12-30 | 0001100682-24-000007 |
| 2024-02-1407:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-24-000238 |
| 2024-01-2416:34 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001100682-24-000004 |
| 2024-01-1616:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001100682-24-000002 |
| 2023-11-1508:31 ET | 8-K | 8.01 Other events | 0001100682-23-000025 |
| 2023-11-0809:06 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001100682-23-000022 |
| 2023-11-0807:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001678 |
| 2023-08-0909:09 ET | 10-Q | Quarterly reportPeriod 2023-07-01 | 0001100682-23-000018 |
| 2023-08-0907:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001294 |
| 2023-05-1516:02 ET | 8-K | 5.07 Shareholder vote results | 0001100682-23-000012 |
| 2023-05-1109:08 ET | 10-Q | Quarterly reportPeriod 2023-04-01 | 0001100682-23-000009 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:52 ET. Listed shows no prices and gives no investment advice.